Intrinsiqs

Is Nuvectis Pharma, Inc. overvalued?

Nuvectis Pharma, Inc. (NVCT) — key valuation metrics and fundamentals.

No verdict
Price
$20.24
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$696.0M
Dividend yield
0.0%
Return on equity
-119.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares NVCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.